Tag:
drug-eluting stent
Latest Headlines
Latest Headlines
Boston Scientific gets FDA nod for heart stent
Boston Scientific ( $BSX ) has received the FDA's OK for the Promus Element system everolimus-eluting stent, which the company will begin marketing immediately. The transition to the Promus Element
Medtronic's Resolute DES shows good results in diabetics
Medtronic's ( $MDT ) Resolute drug-eluting stent showed strong results in diabetic patients with coronary artery disease through one year of follow-up, according to data presented this week at the
Abbott gets nod for Xience Prime
Based on data from the SPIRIT family of trials, the FDA has given its OK for Abbott's ( $ABT ) next-generation Xience Prime everolimus-eluting stent system for the treatment of coronary artery disease.
Medtronic beats Boston Scientific in drug-eluting stent studies
Medtronic's Resolute drug-eluting stent beat out rival Boston Scientific's Taxus DES in late lumen loss after 8 months in a study that helps pave the way for Japanese regulatory approval for
Micell enrolls first patient in MiStent trial
Durham, NC-based Micell Technologies has enrolled the first patient in DESSOLVE I, a first-in-human clinical trial of the company's investigational MiStent drug-eluting coronary stent system.
Study: Bare-metal stents just as good as drug-eluting ones
Five-year data from the PASSION trial reveal that there is no statistically significant difference in the safety and efficacy of bare-metal and drug-eluting stents in acute heart attack-a finding
